Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Ioxynil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.56 |
| ▸ | ALB | P02768 | 2/20 | 0.56 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ioxynil SCHEMBL5934104 | 0.95 | TTR (0.56) | TTRALBVCAM1MEN1KMT2A | |
| SCHEMBL31038060 | 0.76 | TTR (0.64) | TTRALBVCAM1MEN1KMT2A | |
| Ioxynil SCHEMBL39616 | 0.72 | TTR (1.00) | TTRALBVCAM1MEN1KMT2A | |
| SCHEMBL22197816 | 0.72 | TTR (0.58) | TTRALBVCAM1MEN1KMT2A | |
| SCHEMBL11209099 | 0.72 | TTR (0.58) | TTRALBVCAM1MEN1KMT2A | |
| Ioxynil SCHEMBL1701373 | 0.72 | TTR (1.00) | TTRALBVCAM1MEN1KMT2A | |
| Ioxynil SCHEMBL8211431 | 0.70 | TTR (0.95) | TTRALBVCAM1MEN1KMT2A | |
| Ioxynil SCHEMBL3687268 | 0.70 | TTR (0.95) | TTRALBVCAM1MEN1KMT2A | |
| Ioxynil SCHEMBL1614655 | 0.70 | TTR (0.95) | TTRALBVCAM1MEN1KMT2A | |
| Triiodophenol SCHEMBL31616083 | 0.69 | TTR (0.45) | TTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3060043-B1 | PESTICIDAL COMPOSITIONS AND RELATED METHODS | CORTEVA AGRISCIENCE LLC (US) | 2025-11-26 | — | — | EP | claimed |
| EP-4337017-A1 | HERBICIDE/SAFENER COMBINATION BASED ON SAFENERS FROM THE CLASS OF SUBSTITUTED [(1,5-DIPHENYL-1H-1,2,4-TRIAZOL-3-YL)OXY]ACETIC ACIDS AND THEIR SALTS | Bayer Aktiengesellschaft (DE) | 2024-03-20 | — | — | EP | claimed |
| WO-2022152728-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-07-21 | — | — | WO | claimed |
| WO-2025224076-A1 | SUBSTITUTED ARYLPYRAZINES AND SALTS THEREOF, AND USE THEREOF AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-10-30 | — | — | WO | disclosed |
| US-20250270581-A1 | METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE | MONSANTO TECHNOLOGY LLC (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250228243-A1 | METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE | MONSANTO TECHNOLOGY LLC (US) | 2025-07-17 | — | — | US | disclosed |
| WO-2025103927-A1 | SUBSTITUTED OXYIMINOMETHYLPHENYL URACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025103939-A1 | SULFONIMIDOYL BENZAMIDES WITH HERBICIDAL ACTION | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-22 | — | — | WO | disclosed |
| WO-2025103931-A1 | SUBSTITUTED CYCLOPROPYLOXYPHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2025-05-22 | — | — | WO | disclosed |
| EP-4378314-A2 | HERBICIDAL COMPOSITIONS | Bayer AG (DE) | 2024-06-05 | — | — | EP | disclosed |
| CN-114340393-B | Herbicidal composition | 拜耳公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-3993626-A1 | HERBICIDAL COMPOSITIONS | Bayer Aktiengesellschaft (DE) | 2022-05-11 | — | — | EP | disclosed |
| CN-114340393-A | Herbicidal composition | 拜耳公司 | 2022-04-12 | — | — | CN | disclosed |
| US-20220053762-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-02-24 | — | — | US | disclosed |
| EP-3890489-A1 | HERBICIDE COMPOSITIONS | Bayer Aktiengesellschaft (DE) | 2021-10-13 | — | — | EP | disclosed |
| EP-3890488-A1 | HERBICIDAL COMPOSITIONS | Bayer Aktiengesellschaft (DE) | 2021-10-13 | — | — | EP | disclosed |
| WO-2021001273-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2021-01-07 | — | — | WO | disclosed |
| WO-2020114932-A1 | HERBICIDAL COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-06-11 | — | — | WO | disclosed |
| WO-2020114934-A1 | HERBICIDE COMPOSITIONS | BAYER AKTIENGESELLSCHAFT (DE) | 2020-06-11 | — | — | WO | disclosed |
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2006-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276339-A1 | Methods and compositions for increasing the efficacy of biologically-active ingredients | ENPP1, ENPP3, SMPD1 | TTR 4749/4885ALB 4278/4885VCAM1 4857/4885 |
| US-20220053762-A1 | HERBICIDAL COMPOSITIONS | DDT, GUSB, HDHD5 | TTR 3995/4885ALB 2535/4885VCAM1 4883/4885 |
| US-20250270581-A1 | METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE | PPOX, PTPRG, PAOX | TTR 2432/4885ALB 3035/4885VCAM1 4775/4885 |
| US-20250228243-A1 | METHODS AND COMPOSITIONS FOR PPO HERBICIDE TOLERANCE | UNG, PNPO, PPOX | TTR 3315/4885ALB 3017/4885VCAM1 4688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.